ストックスクリーナーアプリを入手
45.99
3.65%
-1.74
アフターアワーズ：
46.01
0.02
+0.04%
Moderna Inc (MRNA) 最新ニュース
Moderna, Inc. $MRNA Shares Sold by Letko Brosseau & Associates Inc. - MarketBeat
Moderna Inc stock (US60770K1079): Legal chief share sale and vaccine pipeline keep volatility high - AD HOC NEWS
Moderna Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Moderna’s mRNA-4194 cleared for clinic for Lynch syndrome - BioWorld News
Moderna Inc. stock (US60770K1034): Bank of America lifts price target after strong run - AD HOC NEWS
Does Moderna Need to Start Making Money? - The Globe and Mail
Does Moderna Need to Start Making Money? - The Motley Fool
Capital World Investors Makes New Investment in Moderna, Inc. $MRNA - MarketBeat
Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome - Investing News Network
AIPLA, NAM Rally Behind Moderna's Fight Over Vax Patents - Law360
Moderna’s Lynch syndrome cancer vaccine trial gets UK approval - Investing.com UK
Inherited cancer risk for 1 in 300: Moderna mRNA trial targets Lynch syndrome - Stock Titan
Moderna CLO Klinger sells $173,550 in shares By Investing.com - Investing.com India
Moderna CLO Klinger sells $173,550 in shares - Investing.com
Moderna (MRNA) legal chief sells 3,471 shares, exercises options and RSUs - Stock Titan
Moderna (MRNA) CFO details RSU vesting and tax share withholding in Form 4 - Stock Titan
MRNA Maintained by B of A Securities -- Price Target Raised to $34 - GuruFocus
Moderna (NASDAQ:MRNA) Price Target Raised to $34.00 - MarketBeat
Moderna, Inc. (MRNA) Stock Analysis: Evaluating The Potential Amidst Volatility - DirectorsTalk Interviews
Havemeyer Place LP Takes Position in Moderna, Inc. $MRNA - MarketBeat
CIBC Asset Management Inc Increases Stock Holdings in Moderna, Inc. $MRNA - MarketBeat
Aufman Associates Inc Has $1.27 Million Stock Holdings in Moderna, Inc. $MRNA - MarketBeat
How Investors May Respond To Moderna (MRNA) mRNA Advances in Personalized Cancer and Emerging Infectious Diseases - Yahoo Finance
Norges Bank Makes New Investment in Moderna, Inc. $MRNA - MarketBeat
MRNA Stock Quote Price and Forecast - CNN
Why Is Moderna (MRNA) Stock Rocketing Higher Today - Yahoo Finance
Moderna gets good news as it searches for life after Covid - Yahoo Finance Singapore
[144] Moderna, Inc. SEC Filing - Stock Titan
Moderna Inc (MRNA) Stock Price, Trades & News - GuruFocus
Why Moderna Inc (MRNA) May Struggle to Outperform: A Look at Fut - GuruFocus
Moderna Stock: Is MRNA Outperforming the Health Care Sector? - Yahoo Finance
Moderna Inc. stock (US60770K1034): EMA committee backs new RSV vaccine as shares bounce on Nasdaq - AD HOC NEWS
Moderna (MRNA) Climbs 7.5% Ahead of Next Week’s Key Updates - Insider Monkey
Moderna rallies on renewed optimism around its Merck-partnered melanoma vaccine program - Quiver Quantitative
Moderna (MRNA) CFO exercises 2,475 RSUs, 1,197 shares withheld for taxes - Stock Titan
Moderna (MRNA) CLO converts RSUs into stock while 1,047 shares withheld for taxes - Stock Titan
Moderna (MRNA) president exercises RSUs, reports tax share withholding - Stock Titan
Moderna (NASDAQ:MRNA) Trading 8.1% HigherShould You Buy? - MarketBeat
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion - Investing News Network
HEALTH ROUNDS-Radiation-emitting implant improves outcomes after brain cancer surgery - marketscreener.com
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 - Yahoo Finance
Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™” - Yahoo Finance
Moderna CEPI Ebola Vaccine Work Highlights Broader Infectious Disease Ambitions - Yahoo Finance
Moderna to Present at Upcoming Conference in June 2026 - Investing News Network
MRNA Partners With CEPI to Develop Vaccine for Bundibugyo Ebolavirus - Zacks Investment Research
UBS Lifts Valuation On Moderna, Inc. (MRNA) Ahead of Key Pipeline Catalysts - Insider Monkey
Biotech Movers: Moderna, Iovance, ALHC, SMMT in Focus - Gotrade
ASCO: Moderna’s mRNA-based melanoma vaccine shows ‘encouraging’ 5-year survival - BioSpace
Moderna, Inc. $MRNA Shares Acquired by Lingotto Investment Management LLP - MarketBeat
Moderna and other groups get $60mln to develop Ebola vaccine - ZAWYA
Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus - Black Hills Pioneer
Moderna, Inc. $MRNA Holdings Lowered by Geode Capital Management LLC - MarketBeat
AXQ Capital LP Purchases 39,835 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna and other groups get $60 million to develop Ebola vaccine By Reuters - Investing.com
Drugmaker Moderna, other groups get $60 mln to develop Ebola vaccine - Yahoo Finance UK
Moderna, Inc. (MRNA) Discusses Intismeran mRNA Immunotherapy and Phase II KEYNOTE-942 Oncology DataSlideshow (NASDAQ:MRNA) 2026-06-01 - Seeking Alpha
Why (MRNA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Moderna Tells Fed. Circ. US Must Face COVID Vax Patent Case - Law360
Moderna and other groups get $60 million to develop Ebola vaccine - Reuters
Moderna (MRNA) and Merck (MRK) Report Promising Results for Canc - GuruFocus
Moderna gets $50M investment for Ebola vaccine candidate - Yahoo
2.20%
2.09%
大文字化:
|
ボリューム (24 時間):